Price Wealth’s Jazz Pharmaceuticals JAZZ Stock Holding History

Price Wealth’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14	Closed	-$2K	–	428
2019 Q3	$2K	Hold	14	–	–	﹤0.01%	249
2019 Q2	$2K	Buy	+14	New	+$1.88K	﹤0.01%	249

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Price Wealth's JAZZ Position: Q4 2019 in Review

Price Wealth sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2019, closing a stake of 14 shares — an estimated $2K sold.

Price Wealth first reported a position in JAZZ in Q2 2019 and held it in 2 quarters. The position peaked at $2K in Q3 2019. 446 funds tracked by Wall St. Rank hold JAZZ as of Q4 2019.

Price Wealth reported no remaining Jazz Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Price Wealth sold 14 Jazz Pharmaceuticals shares in Q4 2019, an estimated $2K.
Price Wealth first reported a position in Jazz Pharmaceuticals in Q2 2019 and held it in 2 quarters.
Price Wealth's Jazz Pharmaceuticals position peaked at $2K in Q3 2019.
446 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2019.

Based on Price Wealth's 13F filing for Q4 2019, filed 16 Jan 2020.